To date, only the locoregional approach using 211At coupled with the anti-SDC1 mAb 9E7.4 (211At-9E7.4) has achieved long-term remission in treated animals, with a protection of long-term survivors against tumour rechallenge 63. The gene discussed is SDC1; the disease is neoplasm.